Učitavanje...
Metformin and COVID-19: From cellular mechanisms to reduced mortality
Type 2 diabetes mellitus (T2DM) is associated with both poorer clinical outcomes during the COVID-19 pandemic and an increased risk of death in such hospitalized patients. While the role of glucose control has been emphasized to improve the prognosis, the impact of different glucose-lowering agents...
Spremljeno u:
| Izdano u: | Diabetes Metab |
|---|---|
| Glavni autor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Elsevier Masson SAS.
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7395819/ https://ncbi.nlm.nih.gov/pubmed/32750451 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.diabet.2020.07.006 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|